Comparable stake leader
Joseph Hernandez
SEC ownership of CLARUS THERAPEUTICS INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001286162.
Disclosed value leader
—
Comparable rows
0/2
Latest evidence
20 Apr 2022
- SEC evidence covered
- 3/4/5
- Largest SEC-reported holder
- Joseph Hernandez
- Latest parsed evidence date
- 20 Apr 2022
- CIK
- 0001286162
- Location
- Northbrook, IL
Ownership snapshot
1 signal
Issuer
2 identity fields
Ownership snapshot
Top shareholders of CLARUS THERAPEUTICS INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Joseph Hernandez
Disclosed value leader
—
Comparable rows
0/2
Latest evidence
20 Apr 2022
3/4/5
Some rows are evidence-backed but not safely comparable across classes.
2 rows are not safely comparable across share classes.
Quick read
SEC ownership evidence is available, but the rows are not safely comparable across share classes.
0 of 2 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Detailed SEC evidence table Showing 1-2 of 2 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Joseph Hernandez |
3/4/5
Director, Former 10% owner
|
—
mixed-class rows
|
—
4,747,500 shares
mixed-class rows
|
— | 09 Sep 2021 |
| THOMAS MCNERNEY & PARTNERS LP |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
3,528 shares
|
— | 20 Apr 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 03 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-2 of 2 reporting-owner rows connected to CLARUS THERAPEUTICS INC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
2
Largest Forms 3/4/5 holder
THOMAS MCNERNEY & PARTNERS LP
Net 12M change
$0
Latest report
20 Apr 2022
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| THOMAS MCNERNEY & PARTNERS LP | 10%+ Owner | Mixed | 20 Apr 2022 | |||
| Joseph Hernandez | Director, Former 10% owner | Mixed | 09 Sep 2021 |
Recent insider transactions for CLARUS THERAPEUTICS INC
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.